{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T17:39:40Z","timestamp":1768757980136,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.ejphar.2004.01.004","type":"journal-article","created":{"date-parts":[[2004,2,5]],"date-time":"2004-02-05T05:34:35Z","timestamp":1075959275000},"page":"273-280","source":"Crossref","is-referenced-by-count":40,"title":["SK&amp;F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioural topography"],"prefix":"10.1016","volume":"486","author":[{"given":"Gerard J.","family":"O'Sullivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan L.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Kinsella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Waddington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2004.01.004_BIB1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(98)00970-4","article-title":"SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like\/D2-like receptor synergism","volume":"367","author":"Adachi","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-2999(03)01938-1","article-title":"Prefrontal, accumbal [shell] and ventral striatal mechanisms in jaw movements and non-cyclase-coupled dopamine D1-like receptors","volume":"473","author":"Adachi","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0922-4106(90)90194-3","article-title":"Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy","volume":"188","author":"Andersen","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-2999(98)00825-5","article-title":"The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors","volume":"364","author":"Andringa","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB5","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s002130051124","article-title":"Sub-chronic administration of the dopamine D(1) antagonist SKF 83959 in bilaterally MPTP-treated rhesus monkeys: stable therapeutic effects and wearing-off dyskinesia","volume":"146","author":"Andringa","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0014-2999(92)90690-6","article-title":"Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro","volume":"213","author":"Arnt","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB7","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/1098-2396(20000901)37:3<194::AID-SYN3>3.0.CO;2-A","article-title":"Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists","volume":"37","author":"Berridge","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0306-4522(99)00297-3","article-title":"Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase","volume":"93","author":"Clifford","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0028-3908(99)00150-1","article-title":"Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor","volume":"39","author":"Clifford","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0893-133X(01)00246-9","article-title":"Comparative, topographically-based evaluation of behavioural phenotype and specification of D(1)-like:D(2) interactions in a line of incipient congenic mice with D(2) dopamine receptor \u2018knockout\u2019","volume":"25","author":"Clifford","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF02244332","article-title":"Behavioural evidence for \u201cD-1-like\u201d dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C","volume":"113","author":"Daly","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(91)90459-4","article-title":"A68930: a potent agonist selective for the dopamine D1 receptor","volume":"199","author":"DeNinno","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB13","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1111\/j.1476-5381.1995.tb16420.x","article-title":"Pharmacological characterization of behavioural responses to SK&F 83959 in relation to \u2018D1-like\u2019 dopamine receptors not linked to adenylyl cyclase","volume":"116","author":"Deveney","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF02246102","article-title":"Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset","volume":"117","author":"Gnanalingham","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB15","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0006-2952(95)00035-X","article-title":"Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat\u2014relationship to circling behaviour","volume":"49","author":"Gnanalingham","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0014-2999(01)01110-4","article-title":"Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements","volume":"423","author":"Hasegawa","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB17","doi-asserted-by":"crossref","first-page":"10801","DOI":"10.1523\/JNEUROSCI.22-24-10801.2002","article-title":"Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive","volume":"22","author":"Hollon","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1046\/j.1471-4159.2003.01698.x","article-title":"SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain","volume":"85","author":"Jin","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","article-title":"Multiple receptors for dopamine","volume":"277","author":"Kebabian","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB20","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1126\/science.287.5458.1660","article-title":"Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein","volume":"287","author":"Lezcano","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/syn.10108","article-title":"Phenotypic, ethologically based resolution of spontaneous and D(2)-like vs. D(1)-like agonist-induced behavioural topography in mice with congenic D(3) dopamine receptor \u201cknockout\u201d","volume":"46","author":"McNamara","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/sj.npp.1300008","article-title":"Congenic D(1A) Dopamine receptor mutants: ethologically based resolution of behavioural topography indicates genetic background as a determinant of knockout phenotype","volume":"28","author":"McNamara","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF00427697","article-title":"Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK&F 38393 and selectively blocked by the D1 antagonist SCH 23390","volume":"82","author":"Molloy","year":"1984","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/1098-2396(20010315)39:4<319::AID-SYN1015>3.0.CO;2-1","article-title":"Quantification of D1B(D5) receptors in dopamine D1A receptor-deficient mice","volume":"39","author":"Montague","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-2999(89)90093-9","article-title":"The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction","volume":"160","author":"Murray","year":"1989","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB26","series-title":"Handbook of Experimental Pharmacology: Dopamine in the CNS","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-3-642-56051-4_5","article-title":"D1-like dopamine receptors: molecular biology and pharmacology","author":"Niznik","year":"2002"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1023\/A:1007553004615","article-title":"Optimized binding of [35S]GTPgammaS to Gq-like proteins stimulated with dopamine D1-like receptor agonists","volume":"25","author":"Panchalingam","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0028-3908(01)00011-9","article-title":"SKF83959 exhibits biochemical agonism by stimulating [(35)S]GTP gamma S binding and phosphoinositide hydrolysis in rat and monkey brain","volume":"40","author":"Panchalingam","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0006-3223(01)01189-1","article-title":"Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actions","volume":"50","author":"Peacock","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB30","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0006-3223(98)00017-1","article-title":"A phosphoinositide-linked dopamine D1 receptor mediates repetitive jaw movements in rats","volume":"44","author":"Rosengarten","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB31","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev.pharmtox.39.1.313","article-title":"New insights into dopaminergic receptor function using antisense and genetically altered animals","volume":"39","author":"Sibley","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB33","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C","article-title":"The role of dopamine in epilepsy","volume":"22","author":"Starr","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02252620","article-title":"Seizure promotion by D1 agonists does not correlate with other dopaminergic properties","volume":"6","author":"Starr","year":"1993","journal-title":"J. Neural Transm., Parkinson's Dis. Dement. Sect."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB35","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0028-3908(02)00023-0","article-title":"Phenotypic resolution of spontaneous and D(1)-like agonist-induced orofacial movement topographies in congenic dopamine D(1A) receptor \u2018knockout\u2019 mice","volume":"42","author":"Tomiyama","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB36","first-page":"987","article-title":"Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain","volume":"253","author":"Undie","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB37","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1471-4159.1994.63010222.x","article-title":"Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cyclic AMP formation in brain slices","volume":"63","author":"Undie","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB39","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1046\/j.1471-4159.1994.62052045.x","article-title":"Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain","volume":"62","author":"Undie","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2004.01.004_BIB38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0028-3908(99)00106-9","article-title":"Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways","volume":"39","author":"Undie","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB40","series-title":"Dopamine receptors and transporters: Pharmacology, Structure and Function","first-page":"511","article-title":"Levels of functional interaction between D1-like and D2-like dopamine receptor systems","author":"Waddington","year":"1994"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0278-5846(95)00130-N","article-title":"Behavioural pharmacology of \u2018D-1-like\u2019 dopamine receptors: further subtyping, new pharmacological probes and interactions with \u2018D-2-like\u2019 receptors","volume":"19","author":"Waddington","year":"1995","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2004.01.004_BIB41","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0278-5846(01)00152-X","article-title":"The psychopharmacology\u2013molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion (\u2018knockout\u2019)","volume":"25","author":"Waddington","year":"2001","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904000482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299904000482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T01:55:51Z","timestamp":1550195751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299904000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0014299904000482"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2004.01.004","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}